OpenAlex
PricingAboutJobs
Log inGet started
Work

Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials

HTML

Year: 2003
Type: review
Source: Cancer and Metastasis Reviews
DOI: 10.1023/a:1023047431869
Authors: Maria Pavlaki, Stanley Zucker
Institutions: State University of New York, Stony Brook University, Northport VA Medical Center
Language: English

Topic: Protease and Inhibitor Mechanisms
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: matrix metalloproteinase inhibitors, anticancer drug development, randomized controlled trials, animal models of cancer, tumor biology, drug efficacy
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: TUMOR CELL STROMAL INTERACTIONS IN CANCER
OpenAlex ID: W1504021012
FWCI: 1.489
Cites: 199
Cited by: 238
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms